Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity.

作者: G�nther Bernhardt , Herta Reile , Herbert Birnb�ck , Thilo Spru� , Helmut Sch�nenberger

DOI: 10.1007/BF01192309

关键词:

摘要: Conventionally in vitro cytotoxicity assays are performed as single-end-point determinations. To compensate for the diversity of growth rates among different cell lines this report we describe a computerized kinetic chemosensitivity assay based on quantification biomass by staining cells with crystal violet. As prerequisite four human breast cancer line (MDA-MB-231, MCF-7, T-47-D and ZR-75-1) were characterized regard to oestrogen progesterone receptor content, modal chromosome number proliferation kinetics depending passages culture. With prolonged time culture ZR-75-1 exposed various concentrations cisplatinum dose-related increase drug effect was observed. Owing correction T/C values initial mass (at when is added) sharp distinction between cytostatic cytocidal effects becomes obvious plots corrected versus incubation. The influence untreated control possible courses theoretical inhibition profiles (reflecting cytostatic, transient cytotoxic or well development resistance) their relationship corresponding curves drugtreated discussed. Chemosensitivity diethylstilbestrol dipropionate, tamoxifen, melphalan, cisplatinum, vinblastine, Adriamycin 5-fluorouracil prove considerations be true MDA-MB-231, practice.

参考文章(37)
H. Birnböck, N. Knebel, E. von Angerer, Platinum complexes with a selective action on estrogen receptor-positive mammary tumors. Anti-cancer Drug Design. ,vol. 4, pp. 21- 35 ,(1989)
B. H Czepulkowski, D. E Rooney, Human cytogenetics : a practical approach IRL Press. ,(1986)
Benjamin Drewinko, Pamela R. Roper, Comparison of in vitro methods to determine drug-induced cell lethality. Cancer Research. ,vol. 36, pp. 2182- 2188 ,(1976)
Tommie Sue Tralka, Mary Jo Joyce, Linda W. Engel, Marc E. Lippman, Stephen J. O'Brien, Nathaniel A. Young, Establishment and Characterization of Three New Continuous Cell Lines Derived from Human Breast Carcinomas Cancer Research. ,vol. 38, pp. 3352- 3364 ,(1978)
Graeme J. Finlay, Bruce C. Baguley, The use of human cancer cell lines as a primary screening system for antineoplastic compounds. European Journal of Cancer and Clinical Oncology. ,vol. 20, pp. 947- 954 ,(1984) , 10.1016/0277-5379(84)90169-X
R.J. Gillies, N. Didier, M. Denton, Determination of cell number in monolayer cultures Analytical Biochemistry. ,vol. 159, pp. 109- 113 ,(1986) , 10.1016/0003-2697(86)90314-3
L. V. Rubinstein, R. H. Shoemaker, K. D. Paull, R. M. Simon, S. Tosini, P. Skehan, D. A. Scudiero, A. Monks, M. R. Boyd, Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines Journal of the National Cancer Institute. ,vol. 82, pp. 1113- 1118 ,(1990) , 10.1093/JNCI/82.13.1113
Jean-Louis Formento, Jean-Louis Moll, Mireille Francoual, Bernard Pierre Krebs, Gerard Milano, Nicole Renee, Roger Khater, Marc Frenay, Moise Namer, HPLC micromethod for simultnaeous measurement of estradiol, progesterone, androgen and glucocorticoid receptor levels. Application to breast cancer biopsies European Journal of Cancer and Clinical Oncology. ,vol. 23, pp. 1307- 1314 ,(1987) , 10.1016/0277-5379(87)90113-1
Philip Skehan, James Thomas, Susan J. Friedman, Postconfluency MDCK monolayers as an in vitro model of solid tumor chemosensitivity. Cell Biology and Toxicology. ,vol. 2, pp. 357- 368 ,(1986) , 10.1007/BF00121851